Search clinical trials for: INGAP Peptide

Total 2195 results

Exsulin Corporation

Completed

Safety and Efficacy of INGAP-Peptide in Patients With Type 1 Diabetes

Diabetes Mellitus, Insulin-Dependent

United States
Jewish General Hospital

Completed

Study of Tolerability and Safety of Adding Ustekinumab to INGAP Peptide for 12 Weeks in Adult Patients With TD1 Melitis

Type 1 Diabetes Mellitus

Canada
Exsulin Corporation

Terminated

Tolerability, Safety, and Efficacy Study of INGAP Peptide to Treat Type 1 Diabetes Mellitus in Adults

Type 1 Diabetes Mellitus

United States, Canada
GMP Endotherapeutics

Completed

Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

United States
Exsulin Corporation

Completed

Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes

Diabetes Mellitus, Non-Insulin-Dependent

United States
HighTide Biopharma Pty Ltd

Completed

Study of HTD4010 in Healthy Volunteers

Type 2 Diabetes Mellitus

Australia
Gitte Kronborg
Rigshospitalet, Denmark; Hvidovre University Hospital; Statens Serum Institut; Ministry...

Completed

Immunization With HIV-1 Peptides in Adjuvant for Treatment of Patients With Chronic HIV-infection (HIV-VAC)

HIV INFECTIONS

Denmark
Chang Gung Memorial Hospital

Unknown

Comparison for Oral Negative Pressure Therapy and CPAP for OSA Under Sleep Endoscopy Assistance: A Randomized Controlled Trial

OSA | iNAP | DISE

Taiwan
Somnics, Inc.

Completed

Pivotal Study of the iNAP® in Adults With OSA

Obstructive Sleep Apnea

Taiwan
Somnics, Inc.

Unknown

A Post-marketing Surveillance of the Negative Pressure Sleep Therapy System to Treat Obstructive Sleep Apnea

Obstructive Sleep Apnea (OSA)

Taiwan, Germany
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
Somnics, Inc.

Unknown

Real World Experiences of the iNAP® Lite in OSA Adults in Taiwan

Obstructive Sleep Apnea of Adult

Taiwan
Somnics, Inc.

Terminated

Pilot Study of Negative Pressure Sleep Therapy System to Treat Obstructive Sleep Apnea

Obstructive Sleep Apnea

Taiwan
Egymedicalpedia

Completed

Evaluation of the Effect of Self-Assembling Peptide P11-4

Dental Caries

Egypt
Xequel Bio, Inc.

Completed

Study to Evaluate the Safety of FSR Peptide Versus Placebo Following Punch Biopsy

Wound Heal

Switzerland
Wuerzburg University Hospital

Completed

Dietary Collagen Peptides and Periodontal Inflammation

Gingivitis

Germany
National Cancer Institute (NCI)

Completed

A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas

Rhabdomyosarcoma | Ewing's Sarcoma

United States
Inge Marie Svane

Completed

Dual Vaccine Trial in Myeloproliferative Neoplasms

Polycythemia Vera | Essential Thrombocythemia

Denmark
St Vincent's University Hospital, Ireland
PelvEx

Completed

Perineal Flap Reconstruction Following Surgery for Advanced Pelvic Malignancy

Rectal Cancer | Pelvic Cancer | Flap Necrosis | Flap Disorder | Perioperative Complication | Flap Ischemia

Ireland
Kinki University
Human Genome Center, Institute of Medical Science, University of Tokyo

Completed

Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer

Gastric Cancer

Japan
TCI Co., Ltd.

Completed

Efficacy Testing of Collagen Peptide Drink

Skin Condition

Taiwan
NovoBliss Research Pvt Ltd
Collagen Lifesciences Private Limited

Completed

A Proof of Science, Dose-Response Study to Evaluate the Safety, Efficacy of Different Dosages of Test Treatments

Healthy | Osteoarthritis, Knee | Brittle Nails | Mild to Moderate Acne | Stiffness of Joint, Nec, Involving Ankle and Foot in MDR24_1 | Other Specified Diseases of Hair and Hair Follicles

India
National Institute of Mental Health (NIMH)

Completed

A Phase I Trial of Intranasal Peptide T: Safety, Toxicity, and Pharmacokinetics in Human Immunodeficiency Virus-1 (HIV-1) Infected Patients.

HIV Infections

United States
University of Yamanashi
Human Genome Center, Institute of Medical Science, University of Tokyo

Unknown

A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer

Esophageal Cancer

Japan
National Institute of Mental Health (NIMH)

Completed

A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).

HIV Infections | Cognition Disorders

United States
University of Chicago

Completed

Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

United States
National Institute of Mental Health (NIMH)

Completed

Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.

HIV Infections | Cognition Disorders

United States
Shin Kong Wu Ho-Su Memorial Hospital
National Yang Ming Chiao Tung University

Recruiting

Prescision Medicine in Obstructive Sleep Apnea, Cardiovascular and Cerebrovascular Disease: AI Electrocardiogram Patch Does it All

Sleep Apnea, Obstructive

Taiwan
Creative Peptides Sweden Inc.

Completed

Effect of C-Peptide on Diabetic Peripheral Neuropathy

Diabetes Mellitus, Type 1 | Diabetic Polyneuropathy

Sweden
Advanced Peptides

Completed

Intranasal Peptide T in the Treatment of Painful Peripheral Neuropathy of AIDS

HIV Infections | Peripheral Nervous System Disease

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Recurrent Ovarian Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Malignant Ovarian Mixed Epithelial Tumor | Ovarian Brenner Tumor | Ovarian Mucinous Cystadenocarcinoma and other conditions

United States
National Cancer Institute (NCI)

Completed

Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By Surgery

Stage IV Skin Melanoma | Recurrent Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage IIA Skin Melanoma | Stage IIB Skin Melanoma | Stage IIC Skin Melanoma | Stage IIIA Skin Melanoma | Stage IA Skin Melanoma | Stage IB Skin Melanoma

United States
Medical University of Lodz

Completed

Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis

Myocardial Infarction | Ischemic Stroke | Endocarditis | Patent Foramen Ovale | Embolic Stroke of Undetermined Source | Atrial Fibrillation and Flutter | Cardiac Tumor
International Centre for Diarrhoeal Disease Research...
Suzuhiro Kamaboko Co., Ltd.,Japan

Completed

Acceptability and Efficacy of 'Fish Surimi Peptide' in Under Five Children Suffering From Moderate Acute Malnutrition

Moderate Acute Malnutrition

Bangladesh
University of Copenhagen
EC-FP6 (contract number: LHM-CT-2003-503041); Aditech Pharma AB

Completed

The Role of Peptide YY (PYY)Infusions in Inhibiting Food Intake.

Obesity
Zhujiang Hospital
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Shenzhen Geno-Immune...

Recruiting

CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS

Myelodysplastic Syndromes | Leukemia, Acute Myelogenous (AML) | Leukemia, Acute Lymphocytic (ALL)

China
Craig L Slingluff, Jr

Terminated

Pilot Study of a Breast Cancer Vaccine Plus Poly-ICLC for Breast Cancer (Breast 41)

Breast Cancer

United States
Sel Sanayi Urunleri Ticaret ve Pazarlama A.S.
Alpan Farma Ar-Ge Biyoteknolojileri Ltd.Sti.

Not yet recruiting

Efficacy Evaluation of Hydrolyzed Collagen Peptide on Knees, Hips, and Ankle Pain in Osteoarthritis

Pain, Joint
Assistance Publique - Hôpitaux de Paris

Recruiting

Improvement of Live Babies Rates After ICSI, Using cpFT (FERTICSI)

Infertility | Pregnancy | Oocyte

France
Methodist Health System

Recruiting

Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors (PRRT)

Neuroendocrine Tumors

United States
National Cancer Institute (NCI)

Completed

Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence

Melanoma | Neoplasm Metastasis

United States
National Institute of Arthritis and Musculoskeletal...

Completed

dnaJ Peptide for Relieving Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Charite University, Berlin, Germany

Unknown

WT1 Peptide Vaccination in Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia | Myelodysplastic Syndrome

Germany
Charite University, Berlin, Germany

Unknown

WT1 Peptid Vaccination in Carcinomas

WT1 Expressing Carcinoma

Germany
National Liver Institute, Egypt

Unknown

Safety and Efficacy Study of CENV3 Vaccine to Protect Against HCV Infection (CENV3)

Vaccine Overdose of Undetermined Intent

Egypt
Shixiu Wu

Unknown

Combination of Radiation Therapy and Peptide Specific CTL Therapy in Treating Patients With Esophageal Cancer

Digestive System Diseases | Esophageal Neoplasms | Esophageal Diseases

China
Pfizer

Completed

Safety, Toleration and Pharmacokinetics of Single Intravenous Doses of Peptide YY in Overweight Adults

Obesity

United States
Milton S. Hershey Medical Center

Terminated

Treatment of Advanced Head and Neck Cancer

Carcinoma, Squamous Cell of Head and Neck

United States
Lars Møller Pedersen

Completed

Peptide Vaccination Against PD-L1 and PD-L2 in Relapsed Follicular Lymphoma

Follicular Lymphoma

Denmark
Duke University
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States

Search clinical trials for: INGAP Peptide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations